Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates
-- Presented new preclinical research across multiple programs, including proof-of-concept data from in vivo rodent and large animal studies, as...
Read more-- Presented new preclinical research across multiple programs, including proof-of-concept data from in vivo rodent and large animal studies, as...
Read moreLead Anti-CD27 Monoclonal Antibody Showed High Binding Affinity and Specificity Drives Strong T Cell Activation and Proliferation as well as...
Read moreSAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action lawsuit on...
Read moreSAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on...
Read moreMerrick B. Garland, Attorney General, et al. v. Michael CargillWashington, D.C., Nov. 03, 2023 (GLOBE NEWSWIRE) -- For the third...
Read moreData to be presented as part of gene augmentation therapy presentationRALEIGH, N.C., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Opus Genetics,...
Read moreSAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action lawsuit on...
Read moreKorro will be focused on advancing a wholly owned portfolio of RNA editing programsPost-transaction cash of approximately $170 million expected...
Read moreRoanoke, VA, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Luna Innovations Incorporated (NASDAQ: LUNA) announced today it will report its third-quarter...
Read moreNational Service agency recognizes volunteers who dedicate hundreds of hours to service PVSA awardees with AmeriCorps State and National Director...
Read more